Mitochondrial Mechanisms of Metabolic Reprogramming in Proliferating Cells

Current Medicinal Chemistry

Volumn 22, Issue 20, 2015, Pages 2493-2504

  Sousa, Maria Ines ^a   Rodrigues, Ana Sofia ^a   Pereira, Sandro ^a   Perestrelo, Tania ^a,b   Correia, Marcelo ^a,b   Ramalho Santos, Joao ^a,c  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Glycolysis; metabolism; nuclear reprogramming; oxidative phosphorylation; pluripotency; regenerative medicine

Indexed keywords

ANTIOXIDANT; REACTIVE OXYGEN METABOLITE; SMALL MOLECULE TRANSPORT AGENT;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL PROTOCOL; DISEASE MODEL; ENERGY METABOLISM; GENE DELIVERY SYSTEM; GENETIC TRANSCRIPTION; HUMAN; METABOLISM; METABOLOMICS; MITOCHONDRIAL DYNAMICS; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; REGENERATIVE MEDICINE; SOMATIC CELL; TOXICITY TESTING; ANIMAL; CYTOLOGY; MITOCHONDRION; NEOPLASM; PATHOLOGY; STEM CELL;

ANIMALS; CELL PROLIFERATION; CELLULAR REPROGRAMMING; HUMANS; MITOCHONDRIA; NEOPLASMS; STEM CELLS;

EID: 84938575415     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867322666150514095718     Document Type: Article

References (110)

1. Zhang, D.X.; Gutterman, D.D. Mitochondrial reactive oxygen species-mediated signaling in endothelial cells. Am. J. Physiol. Heart Circ. Physiol., 2006, 292, 2023-2031
2. Bayir, H.; Kagan, V.E. Bench-to-bedside review: Mitochondrial injury, oxidative stress and apoptosis-there is nothing more practical than a good theory. Crit. Care, 2008, 12206-12217
3. Alberts, B.; Johnson, A.; Lewis, J. Molecular biology of the cell. 5th ed.; Garland Science: New York; 2008.
4. Fogg, V.C.; Lanning, N.J.; Mackeigan, J.P. Mitochondria in cancer: at the crossroads of life and death. Chin. J. Cancer, 2011, 30, 526-539
5. Warburg, O. On respiratory impairment in cancer cells. Science, 1956, 124, 269-270
6. Warburg, O. On the origin of cancer cells. Science, 1956, 123, 309-314
7. Vander Heiden, M.G.; Cantley, L.C.; Thompson, C.B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science, 2009, 324, 1029-1033
8. Marelli-berg, F.M.; Fu, H.; Mauro, C. Molecular mechanisms of metabolic reprogramming in proliferating cells: implications for T-cell-mediated immunity. Immunology, 2012, 136, 363-369
9. MacIver, N.J.; Michalek, R.D.; Rathmell, J.C. Metabolic regulation of T-lymphocytes. Annu. Rev. Immunol., 2013, 31, 259-283
10. Cho, Y.M.; Kwon, S.; Pak, Y.K.; Seol, H.W.; Choi, Y.M.; Park, J.; Park, K.S.; Lee, H.K. Dynamic changes in mitochondrial biogenesis and antioxidant enzymes during the spontaneous differentiation of human embryonic stem cells. Biochem. Biophys. Res. Commun., 2006, 348, 1472-1478
11. Chung, S.; Dzeja, P.P.; Faustino, R.S.; Perez-Terzic, C.; Behfar, A.; Terzic, A. Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells. Nat. Clin. Pract. Cardiovasc. Med., 2007, (Suppl 1), S60-S67
12. Folmes, C.D.L.; Nelson, T.J.; Martinez-fernandez, A.; Arrell, D.K.; Lindor, J.Z.; Dzeja, P.P.; Ikeda, Y.; Perez-terzic, C. Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming. Cell Metab., 2011, 14, 264-271
13. Kondoh, H.; Lleonart, M.E.; Nakashima, Y.; Yokode, M.; Tanaka, M.; Bernard, D.; Gil, J.; Beach, D. A high glycolytic flux supports the proliferative potential of murine embryonic stem cells. Antioxid. Redox Signal., 2007, 9, 293-299
14. Varum, S.; Rodrigues, A. S.; Moura, M. B.; Momcilovic, O.; Easley, C. A; Ramalho-Santos, J.; Van Houten, B.; Schatten, G. Energy metabolism in human pluripotent stem cells and their differentiated counterparts. PloS one, 2011, 6, e20914
15. Lehninger, A.L.; Nelson, D.L.; Cox, M.M. Principles of biochemistry. 6th ed.; Freeman: New York, 2013
16. Zhou, S.; Huang, C.; Wei, Y. The metabolic switch and its regulation in cancer cells. Sci. China Life Sci., 2010, 53, 942-958
17. Folmes, C. D. L.; Nelson, T. J.; Dzeja, P. P.; Terzic, A. Energy metabolism plasticity enables stemness programs. Ann. N. Y. Acad. Sci., 2012, 1254, 82-89
18. Guppy, M.; Greiner, E.; Brand, K. The role of the Crabtree effect and an endogenous fuel in the energy metabolism of resting and proliferating thymocytes. Eur. J. Biochem., 1993, 212, 95-99
19. Zhu, S.; Li, W.; Zhou, H.; Wei, W.; Ambasudhan, R.; Lin, T.; Kim, J.; Zhang, K.; Ding, S. Reprogramming of human primary somatic cells by OCT4 and chemical compounds. Cell Stem Cell, 2010, 7, 651-655
20. Frezza, C.; Zheng, L.; Folger, O.; Rajagopalan, K.N.; MacKenzie, E.D.; Jerby, L.; Micaroni, M.; Chaneton, B.; Adam, J.; Hedley, A.; Kalna, G.; Tomlinson, I. P.; Pollard, P. J.; Watson, D. G.; Deberardinis, R. J.; Shlomi, T.; Ruppin, E.; Gottlieb, E. Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase. Nature, 2011, 477, 225
21. Mashima, T.; Seimiya, H.; Tsuruo, T. De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy. Br. J. Cancer, 2009, 100, 1369-1372
22. Gao, P.; Zhang, H.; Dinavahi, R.; Li, F.; Xiang, Y.; Raman, V.; Bhujwalla, Z. M.; Felsher, D. W.; Cheng, L.; Pevsner, J.; Lee, L. A.; Semenza, G. L.; Dang, C.V. HIF-dependent antitumorigenic effect of antioxidants in vivo. Cancer Cell, 2007, 12, 230-238
23. Ihrlund, L.S.; Hernlund, E.; Khan, O.; Shoshan, M.C. 3-Bromopyruvate as inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs. Mol. Oncol., 2008, 2, 94-101
24. Bonnet, S.; Archer, S.L.; Allalunis-Turner, J.; Haromy, A.; Beaulieu, C.; Thompson, R.; Lee, C. T.; Lopaschuk, G. D.; Puttagunta, L.; Bonnet, S.; Harry, G.; Hashimoto, K.; Porter, C. J.; Andrade, M. A.; Thebaud, B.; Michelakis, E. D. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell, 2007, 11, 37-51
25. Bian, L.; Josefsson, E.; Jonsson, I.M.; Verdrengh, M.; Ohlsson, C.; Bokarewa, M.; Tarkowski, A.; Magnusson, M. Dichloroacetate alleviates development of collagen II-induced arthritis in female DBA/1 mice. Arthritis Res. Ther., 2009, 11, R132
26. Lerou, P.H. And Daley, G.Q. Therapeutic potential of embryonic stem cells. Blood Rev., 2005, 19, 321-331
27. Wu, S.M.; Hochedlinger, K. Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat. Cell Biol., 2011, 13, 497-505
28. Gersh, B.J.; Simari, R.D.; Behfar, A.; Terzic, C.M.; Terzic, A. Cardiac cell repair therapy: a clinical perspective. Mayo Clin. Proc., 2009, 84, 876-892
29. Evans, M.J.; Kaufman, M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature, 1981, 292, 154-156
30. Meissen, J.K.; Yuen, B.T.K.; Kind, T.; Riggs, J.W.; Barupal, D.K.; Knoepfler, P.S.; Fiehn, O. Induced Pluripotent Stem Cells Show Metabolomic Differences to Embryonic Stem Cells in Polyunsaturated Phosphatidylcholines and Primary Metabolism. PLoS One, 2012, 7, 1-9
31. Takahashi, K.; Tanabe, K.; Ohnuki, M.; Narita, M.; Ichisaka, T.; Tomoda, K.; Yamanaka, S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 2007, 131, 861-872
32. Walsh, R.M.; Hochedlinger, K. Modeling Rett syndrome with stem cells. Cell, 2010, 143, 499-500
33. Koch, P.; Breuer, P.; Peitz, M.; Jungverdorben, J.; Kesavan, J.; Poppe, D.; Doerr, J.; Ladewig, J.; Mertens, J.; Tuting, T.; Hoffmann, P.; Klockgether, T.; Evert, B.O.; Wullner, U.; Brustle, O. Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease. Nature, 2011, 480, 543-546
34. Jang, J.; Yoo, J.; Lee, J.; Lee, D.R.; Kim, J.Y.; Huh, Y.J.; Kim, Dae-sung; Park, C.; Hwang, D.; Kim, H.; Kang, H.; Kim, Dongwook. Disease-specific induced pluripotent stem cells: a platform for human disease modeling and drug discovery. Exp. Mol. Med., 2012, 44, 202-213
35. Niwa, H. How is pluripotency determined and maintained? Development, 2007, 134, 635-646
36. Martin, G.R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. U. S .A., 1981, 78, 7634-7638
37. Thomson, J., A.; Itskovitz-Eldor, J.; Shapiro, S. S.; Waknitz, M. A.; Swiergiel, J. J.; Marshall, V. S.; Jones, J.M. Embryonic stem cell lines derived from human blastocysts. Science, 1998, 282, 1145-1147
38. Ramalho-Santos, J. Human procreation in unchartered territory: new twists in ethical discussions. Hum. Reprod., 2011, 26, 1284-1287
39. Carvalho, A. S. And Ramalho-Santos, J. How can ethics relate to science? The case of stem cell research. Eur. J. Hum. Gen., 2013, 21, 591-595
40. Kiskinis, E. And Eggan, K. Progress toward the clinical application of patient-specific pluripotent stem cells. J. Clin. Invest., 2010, 120, 51-59
41. Chamberlain, S.J.; Li, X.-J.; Lalande, M. Induced pluripotent stem (iPS) cells as in vitro models of human neurogenetic disorders. Neurogenetics, 2008, 9, 227-235
42. Takahashi, K.; and Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 2006, 126, 663-676
43. Yu, J.; Vodyanik, M.A.; Smuga-Otto, K.; Antosiewicz-Bourget, J.; Frane, J.L.; Tian, S.; Nie, J.; Jonsdottir, G.A.; Ruotti, V.; Stewart, R.; Slukvin, I.I.; Thomson, J.A. Induced pluripotent stem cell lines derived from human somatic cells. Science, 2007, 318, 1917-1920
44. Nguyen, H.N.; Byers, B.; Cord, B.; Shcheglovitov, A.; Byrne, J.; Gujar, P.; Kee, K.; Schule, B.; Dolmetsch, R.E.; Langston, W.; Palmer, T.; Pera, R.R. LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell, 2011, 8, 267-280
45. Soldner, F.; Hockemeyer, D.; Beard, C.; Gao, Q.; Bell, G.W.; Cook, E.G.; Hargus, G.; Blak, A.; Cooper, O.; Mitalipova, M.; Isacson, O.; Jaenisch, R. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell, 2009, 136, 964-977
46. Carey, B.W.; Markoulaki, S.; Hanna, J.; Saha, K.; Gao, Q.; Mitalipova, M.; Jaenisch, R. Reprogramming of murine and human somatic cells using a single polycistronic vector. Proc. Natl. Acad. Sci. U. S .A., 2009, 106, 157-162
47. Sugii, S.; Kida, Y.; Kawamura, T.; Suzuki, J.; Vassena, R.; Yin, Y.Q.; Lutz, M.K.; Berggren, W.T.; Izpisua, Belmonte, J.C.; Evans, R.M. Human and mouse adipose-derived cells support feederindependent induction of pluripotent stem cells. Proc. Natl. Acad. Sci. U .S .A., 2010, 107, 3558-3563
48. Stadtfeld, M.; Brennand, K.; Hochedlinger, K. Reprogramming of pancreatic beta cells into induced pluripotent stem cells. Curr. Biol., 2008, 18, 890-894
49. Loh, Y.H.; Hartung, O.; Li, H.; Guo, C.; Sahalie, J.M.; Manos, P.D.; Urbach, A.; Heffner, G.C.; Grskovic, M.; Vigneault, F.; Lensch, M.W.; Park, I.H.; Agarwal, S.; Church, G.M.; Collins, J.J.; Irion, S.; Daley, G.Q. Reprogramming of T cells from human peripheral blood. Cell Stem Cell, 2010, 7, 15-19
50. Han, J.W.; Yoon, Y.S. Induced pluripotent stem cells: emerging techniques for nuclear reprogramming. Antioxid. Redox Signal., 2011, 15, 1799-1820
51. Mah, N.; Wang, Y.; Liao, M.-C.; Prigione, A.; Jozefczuk, J.; Lichtner, B.; Wolfrum, K.; Haltmeier, M.; Flottman, M.; Schaefer, M.; Hahn, A.; Mrowka, R.; Klipp, E.; Andrade-Navarro, M.A.; Adjaye, J. Molecular Insights into Reprogramming-Initiation Events Mediated by the OSKM Gene Regulatory Network. PLoS One, 2011, 6, e24351
52. Nakagawa, M.; Koyanagi, M.; Tanabe, K.; Takahashi, K.; Ichisaka, T.; Aoi, T.; Okita, K.; Mochiduki, Y.; Takizawa, N.;Yamanaka, S. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol., 2008, 26, 101-106
53. Wernig, M.; Meissner, A.; Cassady, J.P.; Jaenisch, R. c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell, 2008, 2, 10-12
54. Eminli, S.; Utikal, J.; Arnold, K.; Jaenisch, R.; Hochedlinger, K. Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression. Stem Cells, 2008, 26, 2467-2474
55. Kim, J.B.; Zaehres, H.; Wu, G.; Gentile, L.; Ko, K.; Sebastiano, V.; Arauzo-Bravo, M.J.; Ruau, D.; Han, D.W.; Zenke, M.; Scholer, H.R. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature, 2008, 454, 646-650
56. Silva, J.; Barrandon, O.; Nichols, J.; Kawaguchi, J.; Theunissen, T.W.; Smith, A. Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol., 2008, 6, e253
57. Mikkelsen, T.S.; Ku, M.; Jaffe, D.B.; Issac, B.; Lieberman, E.; Giannoukos, G.; Alvarez, P.; Brockman, W.; Kim, T.K.; Koche, R.P.; Lee, W.; Mendenhall, E.; O'Donovan, A.; Presser, A.; Russ, C.; Xie, X.; Meissner, A.; Wernig, M.; Jaenisch, R.; Nusbaum, C.; Lander, E.S.; Bernstein, B.E. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature, 2007, 448, 553-560
58. Park, I.H.; Zhao, R.; West, J.A.; Yabuuchi, A.; Huo, H.; Ince, T.A.; Lerou, P.H.; Lensch, M.W.; Daley, G.Q. Reprogramming of human somatic cells to pluripotency with defined factors. Nature, 2008, 451, 141-146
59. Aoi, T.; Yae, K.; Nakagawa, M.; Ichisaka, T.; Okita, K.; Takahashi, K.; Chiba, T.; Yamanaka, S. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science, 2008, 321, 699-702
60. Hawley, R.G. Does retroviral insertional mutagenesis play a role in the generation of induced pluripotent stem cells? Mol. Ther., 2008, 16, 1354-1355
61. Wu, X.; Li, Y.; Crise, B.; Burgess, S.M. Transcription start regions in the human genome are favored targets for MLV integration. Science, 2003, 300, 1749-1751
62. Howe, S.J.; Mansour, M.R.; Schwarzwaelder, K.; Bartholomae, C.; Hubank, M.; Kempski, H.; Brugman, M. H.; Pike-Overzet, K.; Chatters, S. J.; De Ridder, D.; Gilmour, K. C.; Adams, S.; Thornhill, S.I.; Parsley, K. L.; Staal, F. J.; Gale, R. E.; Linch, D. C.; Bayford, J.; Brown, L.; Quaye, M.; Kinnon, C.; Ancliff, P.; Webb, D. K.; Schmidt, M.; Von Kalle, C.; Gaspar, H. B.; Thrasher, A. J. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J. Clin. Invest., 2008, 118, 3143-3150
63. Li, Z.; Dullmann, J.; Schiedlmeier, B.; Schmidt, M.; von Kalle, C.; Meyer, J.; Forster, M.; Stocking, C.; Wahlers, A.; Frank, O.; Ostertag, W.; Kuhlcke, K.; Eckert, H.G.; Fehse, B.; Baum, C. Murine leukemia induced by retroviral gene marking. Science, 2002, 296, 497
64. Okita, K.; Nakagawa, M.; Hyenjong, H.; Ichisaka, T.; Yamanaka, S. Generation of mouse induced pluripotent stem cells without viral vectors. Science, 2008, 322, 949-953
65. Kim, D.; Kim, C.H.; Moon, J.I.; Chung, Y.G.; Chang, M.Y.; Han, B.S.; Ko, S.; Yang, E.; Cha, K.Y.; Lanza, R.; Kim, K.S. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell, 2009, 4, 472-476
66. Newman, M.A.; Thomson, J.M.; Hammond, S.M. Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing. RNA, 2008, 14, 1539-1549
67. Viswanathan, S.R.; Daley, G.Q.; Gregory, R.I. Selective blockade of microRNA processing by Lin28. Science, 2008, 320, 97-100
68. Xu, Y.; Shi, Y.; and Ding, S. A chemical approach to stem-cell biology and regenerative medicine. Nature, 2008, 453, 338-344
69. Feng, B.; Ng, J.H.; Heng, J.C.D.; Ng, H-H. Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells. Cell Stem Cell, 2009, 4, 301-312
70. Huangfu, D.; Maehr, R.; Guo, W.; Eijkelenboom, A.; Snitow, M.; Chen, A.E.; Melton, D.A. Induction of pluripotent stemcells by defined factors is greatly improved by small-molecule compounds. Nat. Biotechnol., 2008a, 26, 795-797
71. Huangfu, D.; Osafune, K.; Maehr, R.; Guo, W.; Eijkelenboom, A.; Chen, S.; Muhlestein, W.; Melton, D.A. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat. Biotechnol., 2008b, 26, 1269-1275
72. Epsztejn-Litman, S.; Feldman, N.; Abu-Remaileh, M.; Shufaro, Y.; Gerson, A.; Ueda, J.; Deplus, R.; Fuks, F.; Shinkai, Y.; Cedar, H.; Bergman, Y. De novo DNA methylation promoted by G9a prevents reprogramming of embryonically silenced genes. Nat. Struct. Mol. Biol., 2008, 15, 1176-1183
73. Silva, J.; Smith, A. Capturing pluripotency. Cell, 2008, 132, 532-536
74. Lin, T.; Ambasudhan, R.; Yuan, X.; Li, W.; Hilcove, S.; Abujarour, R.; Lin, X.; Hahm, H.S.; Hao, E.; Hayek, A.; Ding, S. A chemical platform for improved induction of human iPSCs. Nat. Methods, 2009, 6, 805-808
75. Marson, A.; Foreman, R.; Chevalier, B.; Bilodeau, S.; Kahn, M.; Young, R.A.; Jaenisch, R. Wnt signaling promotes reprogramming of somatic cells to pluripotency. Cell Stem Cell, 2008, 3, 132-135
76. Ko, Y.H.; Pedersen, P.L.; Geschwind, J.F. Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase. Cancer Lett., 2001, 173, 83-91
77. Stacpoole, P.W. The pharmacology of dichloroacetate. Metabolism, 1989, 38, 1124-1144
78. Maherali, N.; Hochedlinger, K. Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell, 2008, 3, 595-605
79. Lindvall, O. Why is it taking so long to develop clinically competitive stem cell therapies for CNS disorders? Cell Stem Cell, 2012, 10, 660-662
80. Gore, A.; Li, Z.; Fung, H.L.; Agarwal, S.; Antosiewicz-Bourget, J.; Canto, I.; Giorgetti, A.; Israel, M. A.; Kiskinis, E.; Lee, J. H.; Loh, Y. H.; Manos, P. D.; Montserrat, N.; Panopoulos, A. D.; Ruiz, S.; Wilbert, M. L.; Yu, J.; Kirkness, E. F.; Izpisua Belmonte, J. C.; Rossi, D. J.; Thomson, J. A.; Eggan, K.; Daley, G. Q.; Goldstein, L. S.; Zhang, K. Somatic coding mutations in human induced pluripotent stem cells. Nature, 2011, 471, 63-67
81. Hussein, S.M.; Batada, N.N.; Vuoristo, S.; Ching, R.W.; Autio, R.; Narva, E.; Ng, S.; Sourour, M.; Hamalainen, R.; Olsson, C.; Lundin, K.; Mikkola, M.; Trokovic, R.; Peitz, M.; Brustle, O.; Bazett-Jones, D. P.; Alitalo, K.; Lahesmaa, R.; Nagy, A.; Otonkoski, T. Copy number variation and selection during reprogramming to pluripotency. Nature, 2011, 471, 58-62
82. Mayshar, Y.; Ben-David, U.; Lavon, N.; Biancotti, J.C.; Yakir, B.; Clark, A.T.; Plath, K.; Lowry, W. E.; Benvenisty, N. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell, 2010, 7, 521-531
83. Pasi, C.E.; Dereli-Oz, A.; Negrini, S.; Friedli, M.; Fragola, G.; Lombardo, A.; Van Houwe, G.; Naldini, L.; Casola, S.; Testa, G.; Trono, D.; Pelicci, P. G.; Halazonetis, T. D. Genomic instability in induced stem cells. Cell Death Differ., 2011, 18, 745-753
84. Wu, S.M. And Hochedlinger, K. Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat. Cell Biol., 2011, 13, 497-505
85. Maherali, N.; Sridharan, R.; Xie, W.; Utikal, J.; Eminli, S.; Arnold, K.; Stadtfeld, M.; Yachechko, R.; Tchieu, J.; Jaenisch, R.; Plath, K.; Hochedlinger, K. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell, 2007, 1, 55-70
86. Chin, M. H.; Mason, M. J.; Xie, W.; Volinia, S.; Singer, M.; Peterson, C.; Ambartsumyan, G.; Aimiuwu, O.; Richter, L.; Zhang; J.; Khvorostov, I.; Ott; V.; Grunstein, M.; Lavon, N.; Benvenisty, N.; Croce, C. M.; Clark, A. T.; Baxter, T.; Pyle, A. D.; Teitell, M. A.; Pelegrini, M.; Plath, K.; Lowry, W. E. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell, 2009, 5, 111-123
87. Doi, A; Park, I.H.; Wen, B.; Murakami, P.; Aryee, M.J.; Irizarry, R.; Herb, B.; Ladd-Acosta, C.; Rho, J.; Loewer, S.; Miller, J.; Schlaeger, T.; Daley, G. Q.; Feinberg, A. P. Differential methylation of tissue-and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells; embryonic stem cells and fibroblasts. Nat. Genet., 2009, 41, 1350-1353
88. Deng, J.; Shoemaker, R.; Xie, B.; Gore, A.; LeProust, E.M.; Antosiewicz-Bourget, J.; Egli, D.; Maherali, N.; Park, I. H.; Yu, J.; Daley, G. Q.; Eggan, K.; Hochedlinger, K.; Thomson, J.; Wang, W.; Gao, Y.; Zhang, K. Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nat. Biotechnol., 2009, 27, 353-360
89. Hu, B.Y.; Weick, J.P.; Yu, J.; Ma, L.X.; Zhang, X.Q.; Thomson, J.A.; Zhang, S.C. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc. Natl. Acad. Sci. U.S.A., 2010, 107, 4335-4340
90. Prigione, A.; Fauler, B.; Lurz, R.; Lehrach, H.; Adjaye, J. The Senescence-Related Mitochondrial/Oxidative Stress Pathway is Repressed in Human Induced Pluripotent Stem Cells. Stem Cells, 2010, 28, 721-733
91. St. John, J.C.; Ramalho-santos, J.; Gray, H.L.; Petrosko, P.; Rawe, V.Y.; Navara, C.S.; Simerly, C.R.; Schatten, G.P. The expression of mitochondrial DNA transcription factors during early cardiomyocyte. Cloning Stem Cells, 2005, 7, 141-153
92. Varum, S.; Momcilovi, O.; Castro, C.; Ben-Yehudah, a; Ramalho-Santos, J.; Navara, C.S. Enhancement of human embryonic stem cell pluripotency through inhibition of the mitochondrial respiratory chain. Stem Cell Res., 2009, 3, 142-156
93. Suhr, S.T.; Chang, E.A.; Tjong, J.; Alcasid, N.; Perkins, G.; Goissis, M.D.; Ellisman, M.H.; Perez, G.I.; Cibelli, J.B. Mitochondrial rejuvenation after induced pluripotency. PLoS One, 2010, 5, e14095
94. Armstrong, L.; Tilgner, K.; Saretzki, G.; Atkinson, S.P.; Stojkovic, M.; Moreno, R.; Przyborski, S.; Lako, M. Human induced pluripo tent stem cell lines show stress defense human embryonic stem cells. Stem Cells, 2010, 28, 661-673
95. Esteban, M.A.; Wang, T.; Qin, B.; Yang, J.; Qin, D.; Cai, J.; Li, W.; Weng, Z.; Chen, J.; Ni, S.; Chen, K.; Li, Y.; Liu, X.; Xu, J.; Zhang, S.; Li, F.; He, W.; Labuda, K.; Song, Y.; Peterbauer, A.; Wolbank, S.; Redl, H.; Zhong, M.; Cai, D.; Zeng, L.; Pei, D.. Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell, 2010, 6, 71-79
96. Prigione, A.; Lichtner, B.; Kuhl, H.; Struys, E.A.; Wamelink, M.; Lehrach, H.; Ralser, M.; Timmermann, B.; Adjaye, J. Human induced pluripotent stem cells harbor homoplasmic and heteroplasmic mitochondrial DNA mutations while maintaining human embryonic stem cell-like metabolic reprogramming. Stem Cells, 2011, 29, 1338-1348
97. Zhang, J.; Khvorostov, I.; Hong, J. S.; Oktay, Y.; Vergnes, L.; Nuebel, E.; Wahjudi, P. N.; Setoguchi, K.; Wang, G.; Do, A.; Jung, H.-J.; McCaffery, J. M.; Kurland, I. J.; Reue, K.; Lee, W.-N. P.; Koehler, C. M.; Teitell, M. UCP2 regulates energy metabolism and differentiation potential of human pluripotent stem cells. EMBO J., 2011, 30, 4860-4873
98. Panopoulos, A.D.; Yanes, O.; Ruiz, S.; Kida, Y.S.; Diep, D.; Tautenhahn, R.; Herrerias, A.; Batchelder, E.M.; Plongthongkum, N.; Lutz, M.; Berggren, W.T.; Zhang, K.; Evans, R.M.; Siuzdak, G.; Belmonte, J.C.I. The metabolome of induced pluripotent stem cells reveals metabolic changes occurring in somatic cell reprogramming. Cell Res., 2012, 22, 168-177
99. Folmes, C.D.L.; Nelson, T.J.; Terzic, A. Energy metabolism in nuclear reprogramming. Biomark. Med., 2011, 5, 715-729
100. Yoshida, Y.; Takahashi, K.; Okita, K.; Ichisaka, T.; Yamanaka, S. Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell, 2009, 5, 237-241
101. Chen, M.; Zhang, H.; Wu, J.; Xu, L.; Xu, D.; Sun, J.; He, Y.; Zhou, X; Wang, Z.; Wu, L.; Xu, S.; Wang, J.; Jiang, S.; Zhou, Xiangjun; Hoffman, A.R.; Hu, X.; Hu, J.; Li, T. Promotion of the induction of cell pluripotency through metabolic remodeling by thyroid hormone triiodothyronine-activated PI3K/AKT signal pathway. Biomaterials, 2012, 33, 5514-5523
102. Hewitson, K.S. And Schofield, C.J. The HIF pathway as a therapeutic target. Drug Discov., 2004, 9, 704-711
103. Scarpulla, R.C. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol. Rev., 2008, 88, 611-638
104. Krauss, S., Zhang, C.Y., Lowell, B.B. The mitochondrial uncoupling-protein homologues. Nat. Rev. Mol. Cell Biol., 2005, 6, 248-261
105. Fiehn, O. Metabolomics-the link between genotypes and phenotypes. Plant Mol. Biol., 2002, 48, 155-171
106. Hernandez-Garcia, D.; Wood, C. D.; Castro-Obregon, S.; Covarrubias, L. Reactive oxygen species: A radical role in development? Free Radic. Biol. Med., 2010, 49, 130-143
107. Burdon, R.H. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic. Biol. Med., 1995, 18, 775-794
108. Jones, D.P. Radical-free biology of oxidative stress. Am. J. Physiol. Cell Physiol., 2008, 295, C849-C868
109. Wallace, D. C.; Fan, W.; Procaccio, V. Mitochondrial Energetics and Therapeutics. Ann. Rev. Pathol., 2011, 5, 297-348
110. Prigione, A.; Adjaye, J. Modulation of mitochondrial biogenesis and bioenergetic metabolism upon in vitro and in vivo differentiation of human ES and iPS cells. Int. J. Dev. Biol., 2010, 54, 1729-1741.